{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-012143","form_type":"8-K","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.479950+00:00","generated_at":"2026-06-04T04:27:17.205564+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Xtant Medical reports record FY 2023 revenue $91.3M, up 58% YoY; guides FY 2024 $112M-$116M","bullets":["FY 2023 revenue $91.3M, +58% YoY; organic growth 15%.","Net income $0.7M ($0.01/share) vs net loss $8.5M ($0.09) in 2022.","Non-GAAP adjusted EBITDA $1.0M in 2023, compared to loss of $3.0M in 2022.","FY 2024 revenue guidance $112M-$116M, representing 23%-27% growth.","Gross margin improved 540 bps to 60.8% for 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-012143","json":"https://secwatch.observer/filing/0001493152-24-012143.json","markdown":"https://secwatch.observer/filing/0001493152-24-012143.md","text":"https://secwatch.observer/filing/0001493152-24-012143.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315224012143/0001493152-24-012143-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315224012143/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:27:17.205564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}